In 2025, Conmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Conmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 |
|---|---|---|
Total Scope 1 | 6,252a | 6,607a |
Total Scope 2 | ||
Market-Based | 12,535a | 12,260a |
Location-Based | 12,215a | 11,982a |
Total Scope 3 | N/A | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 4.5478a | 5.055a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Conmed amounted to 18,467 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Conmed decreased by 0.66%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Conmed were 6,252 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2024), Conmed's Scope 1 emissions decreased by 5.37%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2025, Conmed reported Scope 2 greenhouse gas (GHG) emissions of 12,535 tCO₂e using the market-based method and 12,215 tCO₂e using the location-based method.a
Compared to the previous year (2024), Conmed's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Conmed's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2025, Conmed reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2025, Conmed reported Scope 1 greenhouse gas (GHG) emissions of 6,252 tCO₂e and total revenues of USD 1,375 millions. This translates into an emissions intensity of 4.55 tCO₂e per millions USD.a
In 2025, Conmed reported a Scope 1 emissions intensity of 4.55 tCO₂e per millions USD. Compared to the peer group median of 2.65, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2025, Conmed ranked 16 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Conmed is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a